Matritech is a medical device company. Matritech is a leading developer of proteomics-based diagnostic products for the early detection of cancer. Using its patented proteomics technology, Matritech has identified proteins correlated with breast, bladder, prostate, cervical and colon cancers. Matritech employs proteomics to create diagnostic products.
Missing: Matritech's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Matritech's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Matritech
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Matritech is included in 1 Expert Collection, including Omics.
Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data
Matritech Frequently Asked Questions (FAQ)
When was Matritech founded?
Matritech was founded in 1987.
Where is Matritech's headquarters?
Matritech's headquarters is located at 330 Nevada St., 2nd Fl., Newton.
What is Matritech's latest funding round?
Matritech's latest funding round is Acquired.
How much did Matritech raise?
Matritech raised a total of $30.33M.
Who are the investors of Matritech?
Investors of Matritech include Alere, ProMed Capital, Tekla Capital Management, SDS Capital Partners, Alpha Capital Partners and 41 more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.